+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3D Printed Drugs Market by 3D Printing Technology, Material, Dosage Form, Drug Release, Therapeutic Area, End User - Global Forecast to 2030- Product Image
3D Printed Drugs Market by 3D Printing Technology, Material, Dosage Form, Drug Release, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Sale

3D Printed Drugs Market by 3D Printing Technology, Material, Dosage Form, Drug Release, Therapeutic Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4857884
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The 3D Printed Drugs Market is undergoing significant change as advanced additive manufacturing enables pharmaceutical stakeholders to reconfigure production strategies, improve precision, and deliver customized therapeutics at demand-driven scale. Senior leaders benefit from an integrated perspective on evolving technologies, market shifts, and actionable pathways for strategic planning in this high-growth arena.

Market Snapshot: Outlook for the 3D Printed Drugs Market

The 3D printed drugs market demonstrated robust expansion from USD 331.22 million in 2024 to USD 380.50 million in 2025. This growth is propelled by continuous innovation and is forecasted to maintain a compound annual growth rate (CAGR) of 14.47%, ultimately reaching USD 745.40 million by 2030. Industry momentum is attributed to the rapid adoption of precision manufacturing, digitally enabled drug development, and the rising demand for tailored dosage solutions across a broad spectrum of therapeutic areas.

Scope & Segmentation

This report delivers a comprehensive analysis of the entire market landscape, highlighting technologies, applications, and regions that are shaping industry practices:

  • 3D Printing Technologies: Includes Fused Deposition Modeling, Inkjet Printing, Selective Laser Sintering, and Stereolithography. Critical technology distinctions are made for nozzle-based, pellet-based, continuous inkjet, drop-on-demand, metal-based, polymer-based, digital light processing, and laser-based applications.
  • Material Types: Covers Biopolymers, Ceramics, Metals, and Polymers, each chosen for their roles in ensuring biocompatibility, structural integrity, and tailored drug release.
  • Dosage Forms: Details the use of Capsules, Implants, Intrauterine Devices, and Tablets, catering to immediate, controlled, and delayed-release therapies.
  • Therapeutic Areas: Focuses on Cardiovascular, Neurology, Oncology, and Orthopedic applications, illustrating both mainstream and specialized pharmaceutical uses.
  • End User Types: Addresses the requirements of Contract Research Organizations, Hospitals & Clinics, Pharmaceutical Companies, and Research Institutes.
  • Regional Coverage: Analyzes trends across the Americas (notably the United States, Canada, Brazil, and Mexico), Europe, Middle East & Africa (including Germany, France, United Kingdom, and select Middle Eastern and African nations), and Asia-Pacific (with emphasis on China, India, Japan, and other regional leaders).
  • Key Companies Profiled: Reviews strategic developments from Aprecia Pharmaceuticals, LLC; Triastek Co., Ltd.; FabRx Limited; Additive Pharma ApS; and 3D Bioprinting Solutions Ltd.

Key Takeaways for Senior Leadership

  • Adoption of three-dimensional printing is streamlining pharmaceutical development cycles, enabling rapid prototyping and facilitating on-demand production closer to the point of care.
  • Decentralized manufacturing reduces dependence on traditional batch processing and supports resilience in global and regional pharmaceutical supply chains.
  • Collaborations between healthcare providers, technology developers, and research institutions are fostering innovation, particularly in individualized dose printing and complex drug delivery mechanisms.
  • Regulatory agencies are adapting frameworks to address quality assurance, process validation, and post-market monitoring as new products and technologies enter clinical practice.
  • Strategic supplier partnerships and local ecosystem cultivation help companies reduce logistics costs, mitigate sourcing risks, and respond agilely to trade or economic pressures.
  • End users are integrating additive manufacturing to improve patient outcomes and gain operational efficiencies across a range of clinical and research settings.

Tariff Impact: 2025 Dynamics

Recent US tariff implementations have increased the cost of importing critical raw materials and equipment for 3D drug printing. Companies are responding by revising procurement strategies, investing in domestic sourcing, and collaborating under free trade agreements to stabilize access. These pressures have also accelerated research on alternatives and local supply chain development, spurring both risk mitigation and innovation across the value chain.

Methodology & Data Sources

This market intelligence is rooted in rigorous secondary and primary research, leveraging scientific publications, proprietary databases, company filings, and expert interviews. Structured discussions with stakeholders, combined with triangulated data validation and peer review, ensure robust and actionable insights suited to strategic planning needs.

Why This Report Matters

  • Enables strategic investment by mapping competitive landscapes, emerging segments, and regional growth opportunities for decision-makers.
  • Supports risk management and future-readiness by assessing the impact of policy changes and supply chain developments on core manufacturing processes.
  • Delivers a holistic, data-driven resource to guide product innovation, operational improvement, and partnership strategies in the evolving 3D printed drugs sector.

Conclusion

The 3D printed drugs market is positioned for continued advancement. Cross-disciplinary collaboration, supply chain agility, and regulatory adaptation will be key to realizing the full promise of additive manufacturing in pharmaceuticals.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. 3D Printed Drugs Market, by 3D Printing Technology
8.1. Introduction
8.2. Fused Deposition Modeling
8.2.1. Nozzle-Based
8.2.2. Pellet-Based
8.3. Inkjet Printing
8.3.1. Continuous Inkjet
8.3.2. Drop on Demand
8.4. Selective Laser Sintering
8.4.1. Metal-Based
8.4.2. Polymer-Based
8.5. Stereolithography
8.5.1. Digital Light Processing
8.5.2. Laser-Based
9. 3D Printed Drugs Market, by Material
9.1. Introduction
9.2. Biopolymers
9.3. Ceramics
9.4. Metals
9.5. Polymers
10. 3D Printed Drugs Market, by Dosage Form
10.1. Introduction
10.2. Capsules
10.3. Implants
10.4. Intrauterine Devices
10.5. Tablets
11. 3D Printed Drugs Market, by Drug Release
11.1. Introduction
11.2. Controlled Release
11.3. Delayed Release
11.4. Immediate Release
12. 3D Printed Drugs Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular
12.3. Neurology
12.4. Oncology
12.5. Orthopedic
13. 3D Printed Drugs Market, by End User
13.1. Introduction
13.2. Contract Research Organizations
13.3. Hospitals & Clinics
13.4. Pharmaceutical Companies
13.5. Research Institutes
14. Americas 3D Printed Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa 3D Printed Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific 3D Printed Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Aprecia Pharmaceuticals, LLC
17.3.2. Triastek Co., Ltd.
17.3.3. FabRx Limited
17.3.4. Additive Pharma ApS
17.3.5. 3D Bioprinting Solutions Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. 3D PRINTED DRUGS MARKET MULTI-CURRENCY
FIGURE 2. 3D PRINTED DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NOZZLE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY PELLET-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTINUOUS INKJET, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DROP ON DEMAND, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY METAL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY LASER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY BIOPOLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY METALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DELAYED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. CANADA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 71. CANADA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 72. CANADA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 73. CANADA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 74. CANADA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 75. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 77. CANADA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 78. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 81. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 82. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 83. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 88. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 132. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 133. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 134. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 135. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 136. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 138. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 139. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 142. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 143. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 144. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 145. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 146. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 149. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ITALY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 162. ITALY 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 163. ITALY 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 164. ITALY 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 165. ITALY 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 166. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 168. ITALY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 169. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 172. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 173. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 174. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 175. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 176. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 179. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 212. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 213. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 214. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 215. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 216. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 218. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 219. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. QATAR 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 232. QATAR 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 233. QATAR 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 234. QATAR 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 235. QATAR 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 236. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 237. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 238. QATAR 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 239. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 242. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 243. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 244. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 245. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 246. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 247. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 248. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 249. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 272. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 273. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 274. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 275. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 276. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 277. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 278. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 279. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 282. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 283. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 284. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 285. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 286. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 287. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 288. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 289. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 302. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 303. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 304. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 305. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 306. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 307. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 308. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 309. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. POLAND 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 311. POLAND 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 312. POLAND 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 313. POLAND 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 314. POLAND 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 315. POLAND 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 316. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 317. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 318. POLAND 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 319. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 341. CHINA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. CHINA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2030 (USD MILLION)
TABLE 343. CHINA 3D PRINTED DRUGS MARKET SIZE, BY INKJ

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this 3D Printed Drugs market report include:
  • Aprecia Pharmaceuticals, LLC
  • Triastek Co., Ltd.
  • FabRx Limited
  • Additive Pharma ApS
  • 3D Bioprinting Solutions Ltd

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 380.5 Million
Forecasted Market Value ( USD ) by 2030 $ 745.4 Million
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

3D Printed Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

3D Printed Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 81 Pages
  • Global
From
Medical Modeling. The Application of Advanced Design and Additive Manufacturing Techniques in Medicine. Edition No. 3. Woodhead Publishing Series in Biomaterials - Product Image

Medical Modeling. The Application of Advanced Design and Additive Manufacturing Techniques in Medicine. Edition No. 3. Woodhead Publishing Series in Biomaterials

  • Book
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 317 Pages
  • Global
From
Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 140 Pages
  • Asia Pacific
From

About the 3D Printed Drug Market

The 3D Printed Drug market is a subset of the Pharmaceutical industry that focuses on the production of drugs using 3D printing technology. This technology allows for the production of drugs with complex geometries and shapes, as well as the ability to customize drugs for individual patients. 3D Printed Drugs are typically produced using a powder-based process, where a powder is spread over a build platform and then fused together using a laser. This process allows for the production of drugs with a high degree of accuracy and precision. The 3D Printed Drug market is expected to grow in the coming years, as the technology becomes more widely adopted. This growth is driven by the potential for improved drug efficacy, as well as the ability to customize drugs for individual patients. Some companies in the 3D Printed Drug market include Aprecia Pharmaceuticals, 3DPharma, and 3D4MD. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.